Efficiency of Speech Therapy in Resistant Hypertensive Patients With Mild Obstructive Sleep Apnea Syndrome
Efficiency of Speech Therapy in Resistant Hypertensive Patients With Mild Obstructive Sleep Apnea Syndrome
The purpose of this study is to analyze the effect of speech therapy on quality of life,
 sleep quality, daytime sleepiness level and apnea-hypopnea index in patients with
 hypertensive patients with mild obstructive apnea syndrome.
The database will include demographic characteristics, cardiovascular risk factors and and
 target-organ damages. Anthropometric measurements (height, weight, and abdominal and neck
 circumference) will be registered. Daytime sleepiness, quality of sleep and quality of life
 wiill be evaluated through the respective questionnaires: Epworth sleepiness scale,
 Pittsburgh Sleep Quality Index (PSQI) and SF-36. In order to evaluate the airway, the
 Mallampati grade will be used in addition to the adapted assessment protocol from Guimarães
 (2009). The differences between the final score and the baseline score will be calculated and
 adjusted by the baseline value found in each of the questionnaires applied. Finally, the
 analysis excluding the patients with suboptimal adherence to speech therapy treatment (less
 than 85%) compared to the control group will be redone. If there are benefits of treatment
 with speech therapy, it will also be offered to the control group after the end of the
 clinical trial. Statistical analysis will be done in the statistical package SPSS version
 19.0 package (SPSS Inc. Chicago, Illinois, USA). Data obtained may be of benefit to future
 patients and will be used only for statistical purposes. The confidentiality of the
 information collected will be guaranteed, thus ensuring the privacy and confidentiality of
 the information. In addition, the data obtained will not be used for other purposes not
 foreseen in the protocol.
Inclusion Criteria:

 -  Patients in follow-up in the Hypertension Program (ProHart) at Hospital Universitário
 Clementino Fraga Filho - UFRJ at least six months;

 -  Patient with Resistant Hypertension and Mild Obstructive Sleep Apnea detected by
 polysomnography;

 -  All participants that give written informed consent.

 Exclusion Criteria:

 -  Age> 85 years;

 -  Cognitive deficit that prevents speech therapy;

 -  Severe clinical events in the last 6 months;

 -  Refusal of the patient to participate in the study;

 -  Pregnancy;

 -  Prior and regular use of CPAP;

 -  Clinical data suggestive of neurological disease with cognitive and / or motor
 sequelae, craniofacial malformation, severe upper airway obstruction, Neuromuscular
 disease, users of hypnotic drugs